Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical

By The Northwire Desk — AI Analysis Jan 07, 2026 · 07:31 GLOW · 0.06 Glow LifeTech Corp.
GLOW · Price

Executive Summary

  • Glow Lifetech announced the launch of its MOD™ and .decimal™ product portfolio on Mendo Medical Cannabis’s national online platform, marking Glow’s first entry into the Canadian medical cannabis distribution channel.
  • The partnership makes all 14 SKUs (next‑generation cannabis products) available to registered medical patients across Canada, including veterans, expanding Glow’s distribution mix for 2026.
  • Both CEOs highlighted the strategic fit and growth potential of serving the medical‑first market, positioning Glow for broader customer reach and scalable revenue growth.

Key Details

  • Product Portfolio: Full suite of 14 SKUs under the MOD™ and .decimal™ brands now listed on Mendo’s platform (www.mendomedical.ca).
  • Channel Entry: First formal entry into the Canadian medical cannabis channel; products will be sold to registered patients nationwide.
  • Partner Profile: Mendo Medical Cannabis is a leading national online provider focused on veterans and civilian patients, operating from Quebec with a robust e‑commerce platform.
  • Strategic Rationale (CEO Quote – Glow): Expansion into an “important new channel” aligns with long‑term strategy to build scalable, globally relevant product platforms grounded in effectiveness, consistency, and dose‑control.
  • Strategic Rationale (CEO Quote – Mendo): Collaboration expected to resonate with patient community and enhance access to high‑quality, innovative products.
  • Distribution Impact: Diversifies Glow’s distribution mix alongside existing provincial retailer presence; anticipated to increase market penetration and operational efficiency heading into 2026.

Notable Quotes

“With this launch on Mendo, Glow is expanding into an important new channel and makes our innovative products accessible to medical cannabis patients across Canada for the first time,” – Rob Carducci, CEO, Glow Lifetech.

“We are delighted to work with Glow to offer MOD™ and .decimal™ products to our members through our national sales portal, accessible by medical patients Canada‑wide,” – Josee Bissonnette, CEO, Mendo Medical Cannabis.

Read the original news release →

More from Glow LifeTech Corp.

May 26, 2026 · 07:31

Record Revenue and Debt-Free Status Confirm Growth Trajectory Despite Stagnant Price Action

Earnings Apr 30, 2026 · 07:31

Glow Lifetech Executes National Expansion Strategy Amidst Debt-Free Balance Sheet

Production / Operations Apr 08, 2026 · 07:31

Glow Lifetech posts record FY 2025 revenue, wipes out debt and trims warrant overhang – a turning point for the micro‑cap cannabis player

Earnings Mar 27, 2026 · 07:31

Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired

Financings Feb 03, 2026 · 07:31

Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy

Production / Operations Nov 25, 2025 · 07:31

Glow Lifetech Reports Record Q3 2025 Financial Results; 193% YoY Revenue Growth and Achieves First Positive Cash Flow from Operations

Earnings